152 related articles for article (PubMed ID: 1815207)
1. [3H]desGly-NH2(9)-d(CH2)5[D-Ileu2,Ileu4]AVP: an AVP V2 receptor antagonist radioligand.
Trinder D; Stephenson JM; Gao X; Phillips PA; Risvanis J; Johnston CI
Peptides; 1991; 12(6):1195-200. PubMed ID: 1815207
[TBL] [Abstract][Full Text] [Related]
2. Vasopressin and oxytocin receptors on plasma membranes from rat mammary gland. Demonstration of vasopressin receptors by stimulation of inositol phosphate formation, and oxytocin receptors by binding of a specific 125I-labeled oxytocin antagonist, d(CH2)5(1)[Tyr(Me)2, Thr4,Tyr-NH2(9)]OVT.
Soloff MS; Fernström MA; Fernström MJ
Biochem Cell Biol; 1989; 67(2-3):152-62. PubMed ID: 2546575
[TBL] [Abstract][Full Text] [Related]
3. Properties of [3H]1-desamino-8-D-arginine vasopressin as a radioligand for vasopressin V2-receptors in rat kidney.
Marchingo AJ; Abrahams JM; Woodcock EA; Smith AI; Mendelsohn FA; Johnston CI
Endocrinology; 1988 Apr; 122(4):1328-36. PubMed ID: 2964362
[TBL] [Abstract][Full Text] [Related]
4. C-terminal deletions in agonistic and antagonistic analogues of vasopressin that improve their specificities for antidiuretic (V2) and vasopressor (V1) receptors.
Manning M; Misicka A; Olma A; Klis WA; Bankowski K; Nawrocka E; Kruszynski M; Kolodziejczyk A; Cheng LL; Seto J
J Med Chem; 1987 Dec; 30(12):2245-52. PubMed ID: 2960812
[TBL] [Abstract][Full Text] [Related]
5. [3H]AVP binding to rat renal tubular receptors during long-term treatment with an antagonist of arginine vasopressin.
Mah SC; Whitebread SE; De Gasparo M; Hofbauer KG
Peptides; 1988; 9(3):595-600. PubMed ID: 3420014
[TBL] [Abstract][Full Text] [Related]
6. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
[TBL] [Abstract][Full Text] [Related]
7. Effects of an orally active vasopressin V1 receptor antagonist.
Burrell LM; Phillips PA; Stephenson J; Risvanis J; Hutchins AM; Johnston CI
Clin Exp Pharmacol Physiol; 1993 May; 20(5):388-91. PubMed ID: 8391950
[TBL] [Abstract][Full Text] [Related]
8. [125I]-[d(CH2)5, Sar7]AVP: a selective radioligand for V1 vasopressin receptors.
Kelly JM; Abrahams JM; Phillips PA; Mendelsohn FA; Grzonka Z; Johnston CI
J Recept Res; 1989; 9(1):27-41. PubMed ID: 2521670
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of the rat liver AVP receptor using [125I][d(CH2)5'sarcosine7]AVP.
Trinder D; Kelly JM; Fernley R; Mooser V; Phillips PA; Johnston CI
Clin Exp Pharmacol Physiol; 1992 Apr; 19(4):253-60. PubMed ID: 1516273
[TBL] [Abstract][Full Text] [Related]
10. Vasopressin and a nonpeptide antidiuretic hormone receptor antagonist (OPC-31260).
Burrell LM; Phillips PA; Stephenson JM; Risvanis J; Johnston CI
Blood Press; 1994 Mar; 3(1-2):137-41. PubMed ID: 8199714
[TBL] [Abstract][Full Text] [Related]
11. Vasopressin receptors in rat brain and kidney: studies using a radio-iodinated V1 receptor antagonist.
Phillips PA; Kelly JM; Abrahams JM; Grzonka Z; Paxinos G; Mendelsohn FA; Johnston CI
J Hypertens Suppl; 1988 Dec; 6(4):S550-3. PubMed ID: 2977179
[TBL] [Abstract][Full Text] [Related]
12. Vasopressin increases cytosolic free [Ca2+] in the neonatal rat cardiomyocyte. Evidence for V1 subtype receptors.
Xu YJ; Gopalakrishnan V
Circ Res; 1991 Jul; 69(1):239-45. PubMed ID: 2054937
[TBL] [Abstract][Full Text] [Related]
13. Vasopressin (V1) receptor characteristics in rat aortic smooth muscle cells.
Gopalakrishnan V; Xu YJ; Sulakhe PV; Triggle CR; McNeill JR
Am J Physiol; 1991 Dec; 261(6 Pt 2):H1927-36. PubMed ID: 1836312
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of V1a vasopressin receptors in the rat cortical collecting duct.
Ammar A; Roseau S; Butlen D
Am J Physiol; 1992 Apr; 262(4 Pt 2):F546-53. PubMed ID: 1533099
[TBL] [Abstract][Full Text] [Related]
15. Interaction of a vasopressin antagonist with vasopressin receptors in the septum of the rat brain.
Dorsa DM; Brot MD; Shewey LM; Meyers KM; Szot P; Miller MA
Synapse; 1988; 2(3):205-11. PubMed ID: 2975069
[TBL] [Abstract][Full Text] [Related]
16. Autoradiographic characterization of binding sites labelled with vasopressin in the brain of a urodele amphibian.
Tripp SK; Moore FL
Neuroendocrinology; 1988 Jul; 48(1):87-92. PubMed ID: 3173642
[TBL] [Abstract][Full Text] [Related]
17. Direct identification of the rat hepatocyte arginine8 vasopressin receptor with a radiolabelled V1-selective antagonist.
Cornett LE; Cate CM
J Recept Res; 1989; 9(1):1-18. PubMed ID: 2915345
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a novel non-peptide vasopressin V1 receptor antagonist (OPC-21268) in the rat.
Burrell LM; Phillips PA; Stephenson J; Risvanis J; Hutchins AM; Johnston CI
J Endocrinol; 1993 Aug; 138(2):259-66. PubMed ID: 8228734
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and some pharmacological properties of potent and selective antagonists of the vasopressor (V1-receptor) response to arginine-vasopressin.
Manning M; Stoev S; Bankowski K; Misicka A; Lammek B; Wo NC; Sawyer WH
J Med Chem; 1992 Jan; 35(2):382-8. PubMed ID: 1531076
[TBL] [Abstract][Full Text] [Related]
20. Oxytocin receptors on cultured astroglial cells. Kinetic and pharmacological characterization of oxytocin-binding sites on intact hypothalamic and hippocampic cells from foetal rat brain.
Di Scala-Guenot D; Strosser MT
Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):491-7. PubMed ID: 1318031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
